Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy”

Showing 20 of 0 results

Not applicableStudy completedNCT00506194
What this trial is testing

Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

Who this might be right for
Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan 60
Large-scale testing (Phase 3)Study completedNCT01645332
What this trial is testing

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Who this might be right for
Type-2-diabetes MellitusNew Onset
Dexa Medica Group 104
Large-scale testing (Phase 3)Ended earlyNCT00762112
What this trial is testing

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 316
Large-scale testing (Phase 3)Ended earlyNCT01834274
What this trial is testing

Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 96
Large-scale testing (Phase 3)Study completedNCT01499095
What this trial is testing

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 811
Not applicableStudy completedNCT01492166
What this trial is testing

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,935
Large-scale testing (Phase 3)Study completedNCT03798080
What this trial is testing

Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 426
Post-approval studies (Phase 4)Study completedNCT00551538
What this trial is testing

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 15
Post-approval studies (Phase 4)Ended earlyNCT00687453
What this trial is testing

Insulin Glargine Versus Twice-Daily NPH

Who this might be right for
Type 2 Diabetes Mellitus
Charles Drew University of Medicine and Science 27
Early research (Phase 1)Study completedNCT01341392
What this trial is testing

Drug-drug Interaction Study(CKD-501, Amlodipine)

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 25
Not applicableStudy completedNCT00825643
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 18,481
Not applicableNo Longer AvailableNCT00948493
What this trial is testing

Treatment Use of Generex Oral-lyn™ in Patients With Diabetes

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Generex Biotechnology Corp.
Early research (Phase 1)Study completedNCT06124560
What this trial is testing

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Who this might be right for
BioequivalenceDiabetes Mellitus, Type 2
Galenicum Health 58
Post-approval studies (Phase 4)Study completedNCT01022762
What this trial is testing

Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 440
Post-approval studies (Phase 4)Study completedNCT00455858
What this trial is testing

Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 87
Large-scale testing (Phase 3)Study completedNCT00783744
What this trial is testing

Insulin Glargine Combination Therapies in Type II Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 375
Early research (Phase 1)Study completedNCT02430870
What this trial is testing

TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 48
Large-scale testing (Phase 3)Study completedNCT01719003
What this trial is testing

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Hyperglycemia
Boehringer Ingelheim 1,413
Post-approval studies (Phase 4)Study completedNCT02954692
What this trial is testing

Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 112
Large-scale testing (Phase 3)Ended earlyNCT01647542
What this trial is testing

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 393
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation